Cambridge Personal Statement Example: Medical applicant deciding clinical or health policy route (Score 93)

China's hierarchical diagnosis and treatment system, formally consolidated through national policy directives between 2015 and 2019, was designed to redirect patient flows away from tertiary hospitals toward community health centres and general practitioners. The underlying logic is sound: if primary care can absorb routine demand, specialist capacity is preserved for complex cases and system costs are contained. In practice, however, the referral threshold—the clinical and administrative criteria that determine when a primary care provider escalates a patient upward—operates inconsistently across urban and rural settings, across insurance types, and across provider capacity levels. The result is a system in which the gatekeeping function that is supposed to protect equity may instead reproduce or amplify existing access inequalities. This proposal investigates a specific and tractable version of that problem. It asks: to what extent does variation in primary care referral thresholds, across facility type and geographic setting, explain differential rates of specialist access among patients with comparable clinical need in China's tiered system? Two subsidiary questions follow. First, which threshold characteristics—clinical criteria, administrative requirements, or provider discretion—account for the largest share of observed variation? Second, do insurance scheme differences between urban employee basic insurance and urban-rural resident insurance moderate the relationship between threshold stringency and access outcomes? These questions are bounded. They do not attempt to evaluate the tiered system as a whole, nor do they propose a redesign of referral policy. They ask whether a measurable structural feature of the system predicts a measurable outcome in a way that is amenable to empirical analysis within a twelve-month MPhil research window. The international literature on primary care gatekeeping is substantial. Work by Starfield and colleagues on primary care strength and health equity, and subsequent comparative studies examining gatekeeping stringency across European health systems, establishes that the design of referral mechanisms has distributional consequences that are not reducible to clinical appropriateness alone. Within the China-specific literature, researchers including Yip, Hsiao, and more recently Meng and colleagues have documented the structural tensions in China's health system reform, including the persistent preference among patients for tertiary-level care and the weak enforcement of referral protocols at the primary level. What this literature does not yet resolve is the within-system variation problem at the threshold level. Most China-focused studies examine aggregate utilisation patterns or insurance coverage effects; fewer have isolated the referral threshold itself as a unit of analysis and asked how its design characteristics vary across facility types and what that variation means for patients with equivalent clinical presentations. This proposal addresses that gap by treating referral threshold design as an observable, measurable policy variable rather than a background assumption. The study will use a mixed quantitative design in two stages. The first stage involves secondary analysis of publicly available survey data. The China Health and Retirement Longitudinal Study and the China Family Panel Studies both contain variables on healthcare-seeking behaviour, facility type visited, insurance status, and self-reported unmet need. Logistic regression models will be constructed to estimate the probability of specialist access as a function of facility-level and geographic variables, controlling for clinical need proxies including self-reported chronic condition burden and functional limitation scores, as well as insurance type. The second stage involves structured document analysis of published referral guidelines and threshold criteria across a purposively selected set of provinces representing variation in urbanisation level and health system development. Provincial health commission websites and the National Health Commission policy repository are the primary sources. This stage maps observable threshold characteristics—whether criteria are primarily clinical, administrative, or discretionary—and produces a typology that can be linked back to the utilisation patterns identified in stage one. The choice to work with existing datasets rather than primary survey collection is deliberate. A twelve-month MPhil timeline does not support original fieldwork across multiple provinces, and the available secondary data are sufficiently granular to address the research questions as framed. If access to one dataset is delayed, the other provides a comparable fallback. The document analysis component is low-risk and can proceed in parallel with quantitative work. Months one and two will be devoted to systematic literature review, dataset registration and access confirmation, and finalisation of the analytical framework. Months three through six will cover primary quantitative analysis and document coding. Months seven through nine will integrate findings across the two stages and develop the threshold typology. Months ten through twelve will be reserved for writing, revision, and submission. Ethical risk is low. Secondary analysis of anonymised survey data and publicly available policy documents does not involve human subjects research in the sense requiring full ethics committee review, but the proposal will be submitted for institutional review to confirm this classification. No patient-identifiable data will be used. The main feasibility risk is dataset access delay, which the parallel document analysis stage is designed to absorb. The scope is deliberately constrained. This proposal does not claim to produce a nationally representative causal estimate; it claims to produce a well-specified descriptive and associational analysis that can support stronger causal inference in subsequent doctoral work. The MPhil in Health Policy at Cambridge sits within a research environment that takes health systems analysis seriously as an empirical and policy-relevant enterprise. The programme's emphasis on evidence-informed policy, combined with access to supervisors working on health system reform, comparative health policy, and equity in healthcare access, makes it the appropriate setting for this project. I am particularly interested in working with faculty whose research engages with Asian health system reform and with the methodological challenges of using administrative and survey data to evaluate policy design. The expected contribution is modest and honest. This project will produce a clearer empirical account of how referral threshold variation relates to specialist access inequality in one of the world's largest health systems. That account will be useful to researchers modelling health system reform pathways and to policymakers considering threshold standardisation as a lever for equity improvement. It will also demonstrate that a clinically trained researcher can apply health policy analytical methods to a question that sits at the boundary of clinical and systems thinking—which is precisely the intellectual position this MPhil is intended to develop.